Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer’s Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects
Year: 2016
Type: article
Source: Journal of Alzheimer s Disease
DOI: 10.3233/jad-160373
Authors: Louis De Beaumont, the Alzheimer’s Disease Cooperative Study, Sandra Pelleieux, Louise Lamarre-Théroux, Doris Dea, Judes Poirier
Institutions: Douglas Mental Health University Institute, McGill University
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: Alzheimer's disease, butyrylcholinesterase
Open Access status: closed
OpenAlex ID: W2515370413
